KittyHawk is a venture capital firm based in Santa Monica, California, founded in 2015. It focuses on leading-edge seed to late-stage pre-IPO companies and supports mission-driven entrepreneurs building world-changing organizations. The firm operates two primary strategies: KittyHawk Frontier, which targets seed-stage investments across frontier technologies such as AI, quantum computing, aerospace, healthcare, longevity, climate, and Web3; and KittyHawk Secondaries, which are pre-IPO secondary funds that leverage relationships with Nasdaq Private Markets to access late-stage opportunities. The firm is led by Will Weisman, a former executive director of Singularity University.
SPARK Neuro Inc. is a neuroscience company focused on quantifying brain data to enhance audience engagement in the advertising and entertainment sectors, as well as improving clinical care and therapeutic discovery in healthcare. Founded in 2013 and headquartered in New York, the company utilizes advanced neuroscience tools, including patented neural metrics and machine learning algorithms, to analyze brain activity. Its flagship product, SPARK Scan, is a 10-minute EEG-based evaluation that detects early signs of changes in brain function. By partnering with prestigious institutions, SPARK Neuro aims to deepen the understanding of neurological and psychiatric conditions while making brain health measurement and care more accessible for healthcare professionals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.